Viridian Therapeutics Inc...
(VRDN)
undefined
undefined%
At close: undefined
19.31
0.00%
After-hours Dec 24, 2024, 01:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 102.83M | 155.58M | 42.30M | 45.90M | 24.85M | 32.61M | 47.44M | 3.34M | 10.83M | 5.12M | 209.35K | 112.53K |
| Short-Term Investments | 374.54M | 268.97M | 154.67M | 81.74M | 2.00M | 29.88M | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 604.00K | 7.61M | 1.49M | 857.00K | -523.00K | 50.00K | 50.00K | 258.00K | 15.00K | 90.00K | 690.05K | 45.58K |
| Receivables | 102.00K | 102.00K | 451.00K | n/a | 108.00K | 24.00K | 1.46M | 524.00K | 394.00K | 1.09M | 994.01K | 1.20M |
| Inventory | n/a | -6.62M | n/a | n/a | n/a | n/a | 1.00 | 64.00K | 187.00K | 179.00K | 356.64K | 169.54K |
| Other Current Assets | 9.01M | 6.52M | 2.65M | 1.97M | 5.38M | 5.23M | 4.84M | 330.00K | 642.00K | 399.00K | 495.00K | 185.84K |
| Total Current Assets | 486.48M | 424.55M | 200.16M | 129.61M | 29.74M | 65.37M | 51.87M | 4.26M | 11.73M | 6.79M | 2.05M | 1.66M |
| Property-Plant & Equipment | 3.34M | 2.94M | 2.06M | 787.00K | 523.00K | 727.00K | 563.00K | 625.00K | 1.15M | 1.21M | 928.03K | 1.07M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.95M | 10.54M | 3.55M | 1.64M | 523.00K | 777.00K | 613.00K | 883.00K | 1.17M | 1.30M | 1.62M | 1.12M |
| Total Assets | 490.42M | 435.09M | 203.71M | 131.25M | 30.26M | 66.15M | 52.48M | 4.26M | 12.90M | 8.09M | 3.67M | 2.78M |
| Account Payables | 2.24M | 14.23M | 2.33M | 670.00K | 1.10M | 571.00K | 906.00K | 159.00K | 242.00K | 255.00K | 100.00K | 26.66K |
| Deferred Revenue | 288.00K | 288.00K | 289.00K | 301.00K | 5.01M | 3.79M | n/a | 3.38M | 1.02M | n/a | 76.41K | 788.19K |
| Short-Term Debt | 843.00K | 613.00K | 520.00K | 455.00K | 3.98M | 2.29M | n/a | n/a | 1.10M | 80.00K | 697.06K | 22.59M |
| Other Current Liabilities | 23.27M | 18.21M | 10.50M | 9.25M | 5.11M | 3.87M | 2.99M | 4.43M | 1.12M | 1.65M | 513.31K | 988.19K |
| Total Current Liabilities | 26.64M | 33.35M | 13.64M | 10.67M | 10.18M | 6.73M | 3.90M | 4.58M | 2.47M | 1.99M | 1.39M | 23.60M |
| Long-Term Debt | 20.20M | 4.64M | n/a | n/a | 4.33M | 8.00M | 9.92M | 2.82M | n/a | n/a | n/a | 42.05K |
| Other Long-Term Liabilities | 989.00K | 1.17M | 1.21M | 544.00K | n/a | 66.00K | 152.00K | n/a | 24.00K | 109.00K | 259.35K | 578.80K |
| Total Long-Term Liabilities | 21.77M | 6.68M | 2.36M | 544.00K | 4.33M | 8.07M | 10.07M | 2.82M | 24.00K | 109.00K | 259.35K | 620.85K |
| Total Liabilities | 48.40M | 40.03M | 15.99M | 11.22M | 14.51M | 14.80M | 13.97M | 4.58M | 2.49M | 2.10M | 1.65M | 24.22M |
| Total Debt | 21.05M | 5.26M | 520.00K | 455.00K | 8.30M | 10.30M | 9.92M | 1.04M | 1.10M | 80.00K | 697.06K | 22.63M |
| Common Stock | 540.00K | 414.00K | 239.00K | 42.00K | 349.00K | 308.00K | 226.00K | 7.00K | 106.00K | 38.00K | 27.91K | n/a |
| Retained Earnings | -725.91M | -488.17M | -358.30M | -278.89M | -168.17M | -126.30M | -93.59M | -30.64M | -17.97M | -6.64M | -25.89M | -21.44M |
| Comprehensive Income | 338.00K | -390.00K | -157.00K | -8.00K | n/a | -3.00K | -2.83M | -0.00 | -739.00K | -555.00K | -411.05K | -262.74K |
| Shareholders Equity | 442.02M | 395.06M | 187.72M | 120.04M | 15.75M | 51.34M | 38.51M | -326.00K | 10.41M | 5.99M | 2.03M | -21.44M |
| Total Investments | 374.54M | 268.97M | 154.67M | 81.74M | 2.00M | 29.88M | n/a | n/a | n/a | n/a | n/a | n/a |